he completed his post doctoral training at northwestern university and the university of michigan in 1964 while conducting research for the karmanos institute horwitz synthesized a compound that was to become known as zidovudine azt an antiviral drug used to treat hiv patients zidovudine was initially developed as a treatment for cancer horwitz was also first to synthesize stavudine d4t and zalcitabine ddc two other reverse transcriptase inhibitors used in the treatment of hiv patients also during 1964 he published the first production and demonstration of x gal as a chromogenic substrate after synthesizing azt horwitz went on to create many successful treatments for cancer and other diseases at the time of his most recent findings horwitz was working for the michigan cancer foundation with a federal grant from the national institutes of health he retired in 2005